Keywords: CIT; CIITA; CTLA-4; De novo donor-specific antibodies; Chronic antibody-mediated rejection; Kidney transplantation;
مقالات ISI CIT (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CIT; CIITA; class II major histocompatibility complex transactivator; GR; glucocorticoid receptor; MIF; macrophage migration inhibitory factor; sGC; soluble guanylyl cyclase; Acute stress; Hippocampus; Nitric oxide; Nitric oxide synthase; Pro-inflammatory cyto
Keywords: CIT; Anti-Tumor Immunity; Viral Infection; Survival; Stomach Cancer; APO; apolipoprotein; CIITA; class II major histocompatibility complex trans activator gene; CXCL; CXC motif ligand; CXCR; CXC motif chemokine receptors; DEG; differentially expressed gene; EB
Keywords: CIT; IRF-1; interferon regulatory factor-1; TF; transcription factor; TFBS; transcription factor binding site; YY1; Ying-Yang 1; STAT; signal transducer and activator of transcription; HS; hypersensitive; CIITA; class II transactivator; MHC; major histocompati
Keywords: CIT; Dendritic cells; cytokines; immunotherapy; mast cell; basophil; eosinophil; T cells; regulatory T cells; AHR; Airway hyperresponsiveness; CIITA; MHC class II transactivator; CRTH2; Chemoattractant receptor homologous molecule expressed on TH2 cells (also
Defective T Helper Response of Hepatocyte-Stimulated CD4 T Cells Impairs Antiviral CD8 Response and Viral Clearance
Keywords: CIT; APC; antigen-presenting cell; CIITA; class II transactivator molecule; CFSE; 5-,6-carboxyfluorescein diacetate, succinimidyl ester; IL; interleukin; IFN; interferon; LCMV; lymphocytic choriomeningitis virus; MHC; major histocompatibility complex; Th; T he
Precise immune tolerance for hPSC derivatives in clinical application
Keywords: CIT; AAV; adeno-associated virus; ATIIC; lung alveolar epithelial type II cell; B2M; b-2-microglobulin; BAC; bacterial artificial chromosome; CIITA; class-II MHC trans-activator; CP hESC; hESC lines constitutively expressing CTLA4Ig and programmed death-ligand
MHC class II deficiency: Report of a novel mutation and special review
Keywords: CIT; MHC class II deficiency; CIITA; RFXANK; RFX5; RFXAP;
The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies
Keywords: CIT; Primary testicular diffuse large B-cell lymphoma (PT-DLBCL); NF-κB; Immune-escape; Programmed death ligands; CD274; PDCD1LG2; CIITA;
Expression patterns of NLRC5 and key genes in the STAT1 pathway following infection with Salmonella pullorum
Keywords: CIT; CIITA; class II transactivator; cDNA; complementary DNA; CFU; colony forming units; dpi; day(s) post infection; DMEM; Dulbecco's modified Eagle medium; FBS; fetal bovine serum; hpi; hour(s) post infection; LB; Luria-Bertani; MHC; major histocompatibility
Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition
Keywords: CIT; ABO-I; ABO-incompatible kidney transplantation; CAMR; chronic antibody mediated rejection; CDC; complement-dependent cytotoxicity; CIITA; class II transactivator; DSA; donor-specific antibody; HLA-I; HLA-incompatible kidney transplantation; Kidney transpl
Johne's disease in cattle: an in vitro model to study early response to infection of Mycobacterium avium subsp. paratuberculosis using RNA-seq.
Keywords: CIT; ARG2; arginase 2; CIITA; class II major histocompatibility complex transactivator; CD; Crohn's disease; CSFs; colony-stimulating factors; CISH; cytokine inducible SH2-containing protein; CSF2; granulocyte-macrophage colony-stimulating factor; CSF3; gran
Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs
Keywords: CIT; AMR; Antibody mediated rejection; CIITA; Class II Transactivator; CLIP; Class II associated invariant peptide; dnDSA; De novo Donor HLA Specific Antibodies; DSA; Donor HLA Specific Antibodies; IFNÆ´; Interferon gamma; Ii; Invariant chain; MAC; Membrane At
The arginine methyltransferase PRMT5 regulates CIITA-dependent MHC II transcription
Keywords: CIT; Transcriptional regulation; Epigenetics; PRMT5; CIITA; MHC II; Macrophage
HDAC4 mediates IFN-γ induced disruption of energy expenditure-related gene expression by repressing SIRT1 transcription in skeletal muscle cells
Keywords: CIT; Transcriptional regulation; Epigenetics; HDAC4; CIITA; IFN-γ;
St. John's wort extract and hyperforin inhibit multiple phosphorylation steps of cytokine signaling and prevent inflammatory and apoptotic gene induction in pancreatic β cells
Keywords: CIT; BAD; BCL2-associated agonist of cell death; BIM; BCL2-like 11; CHOP; C/EBP homologous protein; CIITA; Class II major histocompatibility complex transactivator; COX2; Cyclo-oxygenase 2; DP5; Death protein 5; EMSA; Electrophoretic mobility shift assay; ER;
HIC1 epigenetically represses CIITA transcription in B lymphocytes
Keywords: CIT; Transcriptional regulation; Epigenetics; HIC1; CIITA; DNMT;
Diverse cellular and organismal functions of the lysosomal thiol reductase GILT
Keywords: CIT; GILT; IFI30; Antigen presentation; Autoimmunity; Cancer; Redox; GILT; gamma-interferon-inducible lysosomal thiol reductase; CIITA; class II transactivator; TRP1; tyrosinase-related protein 1; MOG; myelin oligodendrocyte glycoprotein; HSV1; herpes simplex
Polycomb recruitment at the Class II transactivator gene
Keywords: CIT; PRC2; polycomb repressive complex 2; EZH2; enhancer of zeste homolog 2; JARID2; jumonji, AT rich interactive domain 2; YY1; Yin-Yang 1; CIITA pIV; class II transactivator promoter IV; MHC; major histocompatibility complex; lncRNA; long non-coding RNA; HOT
A2b adenosine signaling represses CIITA transcription via an epigenetic mechanism in vascular smooth muscle cells
Keywords: CIT; CIITA; class II transactivator; GCN5; general control of amino acid synthesis protein 5; PCAF; p300-and-CBP-associated factor; STAT1; signal transducer and activator of transcription 1; VSMC; vascular smooth muscle cell; WDR5; WD repeat-containing protein
Considerations on regulatory sequences of the distal promoter region of the HLA-G gene
Keywords: CIT; CIITA; class II trans activator; EM; expectation maximization algorithm; GAS; interferon-gama activated site; HLA; human leucocyte antigen; HSE; heat shock element; HSF-1; heat shock factor 1; HWF>1%; haplotypes with frequency higher than 1%; INF; interfe
Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders
Keywords: CIT; AGRP; agouti-related protein; AMPK; AMP-activated protein kinase; AP-1; activator protein-1; BCL10; B-cell lymphoma/leukemia-10; CIITA; class II, major histocompatibility complex, transactivator; DHA; docosahexaenoic acid; E2F1; transcription factor E2F1;
Transcriptional coactivator CIITA, a functional homolog of TAF1, has kinase activity
Keywords: CIT; CIITA; MHC class II; MHC class I; TAF7; Transcription; Kinase
NLRC5: a newly discovered MHC class I transactivator (CITA)
Keywords: CIT; MHC class I; NLR proteins; CIITA;
Immunisation with an allogeneic peptide promotes the induction of antigen-specific MHC IIpos CD4+ rat T cells demonstrating immunostimulatory properties
Keywords: CIT; Allogeneic peptide; Autostimulation; T cell-mediated antigen presentation; MHC class II; Antigen processing and presentation; T lymphocytes; Immunoregulation; CIITA;
Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells
Keywords: CIT; PU.1; class II transactivator; dendritic cells; MHC class II; BMDC; Bone marrow-derived dendritic cell; cDC; Conventional dendritic cell; ChIP; Chromatin immunoprecipitation; CIITA; Class II transactivator; CREB; Cyclic AMP response element binding; DC
Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation
Keywords: CIT; 19S ATPases; Ubiquitin; Proteasome; CIITA; MHC II
Involvement of NF-κB in changes of IFN-γ-induced CIITA/MHC-II and iNOS expression by influenza virus in macrophages
Keywords: CIT; IFN-γ; interferon-gamma; MHC; major histocompatibility complex; iNOS; inducible nitric oxide synthase; NF-κB; nuclear factor-κB; CIITA; class II, major histocompatibility complex, transactivator; NO; nitric oxide; JAK; janus kinase; STAT; signal transd
Both MHC and non-MHC genes regulate inflammation and T-cell response after traumatic brain injury
Keywords: CIT; Traumatic brain injury; MHC class II; T-cells; Inflammation; Genes; Ciita; Rat strains
Cellular immunity and immunopathology in autoimmune Addison's disease
Keywords: CIT; 17OH; steroid cytochrome P450 17-alpha-hydroxylase; 21OH; steroid cytochrome P450 21-hydroxylase; AAD; autoimmune Addison's disease; ACA; adrenal cortex autoantibodies; ADCC; antibody dependent cellular cytotoxicity; AIRE; autoimmune regulator; APC; antig
Major Histocompatibility Complex Class II Transactivator Inhibits Cysteine-rich 61 Expression in Osteoblastic Cells and Its Implication in the Pathogenesis of Periapical Lesions
Keywords: CIT; Apical periodontitis; bone resorption; CIITA; Cyr61; osteoblasts
Capsaicin inhibits IFN-γ-induced MHC class II expression by suppressing transcription of class II transactivator gene in murine peritoneal macrophages
Keywords: CIT; APC, antigen presenting cell; CAP, capsaicin; CIITA, class II transactivator; IFN, interferon; MHC, major histocompatibility complex; NO, nitric oxideMHC class II; CIITA; Capsaicin; NO; Macrophage
The locus control region of the MHC class II promoter acts as a repressor element, the activity of which is inhibited by CIITA
Keywords: CIT; MHC class II; Gene regulation; CIITA; Macrophages
Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit
Keywords: CIT; Gene regulatory network subcircuits; HLA-DR; Oct-1; CIITA; Retinoblastoma protein;
HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells
Keywords: CIT; CIITA; HDAC2-mediated deacetylation; Transcriptional regulation; Protein degradation; RFX5; MHC II; Collagen type I; Smooth muscle cell; Macrophage; Atherogenesis
NOD-like subfamily of the nucleotide-binding domain and leucine-rich repeat containing family receptors and their expression in channel catfish
Keywords: CIT; BIR; baculovirus inhibitor of apoptosis protein repeat; CARD; caspase recruitment domain; CIITA; class IImajor histocompatibility complex, transactivator; HET-E; bacterial nucleotide triphosphatase protein; IPAF; ice protease-activating factor; LRR; leuci
PPARγ enhances IFNγ-mediated transcription and rescues the TGFβ antagonism by stimulating CIITA in vascular smooth muscle cells
Keywords: CIT; PPARγ; IFN-γ; TGF-β; CIITA; MHC II; Collagen type I; Transcriptional regulation; Protein degradation; Atherogenesis
Interferon-triggered transcriptional cascades in the oligodendroglial lineage: A comparison of induction of MHC class II antigen between oligodendroglial progenitor cells and mature oligodendrocytes
Keywords: CIT; Oligodendroglial lineage; Interferon; MHC; IRF; CIITA; DNA methylation
Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27
Keywords: CIT; IL-27; MHC; CIITA; IRF-1; THP-1
Invariant chain+ N2a neuroblastoma cells stably expressing the class II MHC transactivator CIITA fail to stimulate anti-tumor immunity
Keywords: CIT; Invariant chain; CIITA; Neuroblastoma; N2a; Tumor vaccine; MHC II
The 19S proteasome ATPase Sug1 plays a critical role in regulating MHC class II transcription
Keywords: CIT; MHC class II; CIITA; Transcription factors; Gene regulation; 26S proteasome; 19S proteasome
Enhanced production of p24 Gag protein in HIV-1-infected rat cells fused with uninfected human cells
Keywords: CIT; HIV-1; Rat model; Cell fusion; Cyclin T1; CDK9; CRM1; HP68; CIITA
Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator
Keywords: CIT; IL-27; MHC; CIITA; IRF-1; Endothelial cells
Positive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoter
Keywords: CIT; PRDI-BF1; Blimp-1; CIITA; B lymphocytes; Multiple myeloma
MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-γ
Keywords: CIT; Myeloma; CIITA; IFN-γ; IFN-γR1; STAT1; IRF-1; IRF-2; PRDI-BF1; Blimp-1
T84-Intestinal Epithelial Exosomes Bear MHC Class II/Peptide Complexes Potentiating Antigen Presentation by Dendritic Cells
Keywords: CIT; APC; antigen-presenting cell; CIITA; MHC class II transactivator; DC; dendritic cells; IEC; intestinal epithelial cells; IDC; immature DC; HSA; human serum albumin; I/MDC; maturing DC; MDC; mature DC; MHC; major histocompatibility complex;
CREB and phospho-CREB interact with RFX5 and CIITA to regulate MHC class II genes
Keywords: CIT; MHC class II; Transcription; CREB; CIITA; RFX; Gene expression
Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice
Keywords: CIT; Collagen; DNA binding proteins; CIITA; IFN-γ;
Not polymorphism but methylation of class II transactivator gene promoter IV associated with persistent HBV infection
Keywords: CIT; HBV; hepatitis B virus; CIITA; class II transactivator; MHC; class II major histocompability complex; HCC; hepatocellular carcinoma; CHB; chronic hepatitis B; LC; liver cirrhosis; AHB; acute hepatitis B; MSP; methylation-specific PCR; Class II transactiva
Prolonged MHC class II expression and CIITA transcription in human keratinocytes
Keywords: CIT; CIITA; Keratinocytes; MHC class II; Promoter; Transcription